XML 38 R26.htm IDEA: XBRL DOCUMENT v3.25.0.1
Scienture Inc. 2020 Stock Option and Grant Plan (Tables) - Scienture Inc [Member]
 6 Months Ended 12 Months Ended
Jun. 30, 2024
Dec. 31, 2023
Summary of Stock Option Activity

A summary of the Company’s stock option activity under the Plans is as follows:

 

   Outstanding
Options		   Weighted-
Average
Exercise
Price		   Weighted-
Average
Remaining
Term
(Years)		 
Balance as of December 31, 2023   655,000   $0.90    7.56 
Granted   142,199    1.13      
Exercised   -    -      
Cancelled and forfeited   -    -      
Balance as of June 20, 2024   797,199   $0.94    6.21 
                
Vested and exercisable as of June 30, 2024   499,089   $0.84    5.62 

A summary of the Company’s stock option activity under the Plans is as follows:

 

   Outstanding
Options		   Weighted-
Average
Exercise
Price		   Weighted-
Average
Remaining
Term
(Years)		 
Balance as of December 31, 2022   560,000   $0.83    7.95 
Granted   185,000    1.13      
Exercised   -    -      
Cancelled and forfeited   (90,000)   -      
Balance as of December 31, 2023   655,000   $0.90    7.56 
                
Vested and exercisable as of December 31, 2023   410,065   $0.84    6.84 
Schedule of Stock-based Compensation Expense

The Company recorded stock-based compensation expense in the Statement of Operations and Comprehensive Loss for the periods presented as follows:

 

   2024   2023 
   June 30, 
   2024   2023 
General and Administrative Expenses  $44,837   $39,724 
Total stock-based compensation expense  $44,837   $39,724 

The Company recorded stock-based compensation expense in the Statement of Operations and Comprehensive Loss for the periods presented as follows:

 

   2023   2022 
   December 31, 
   2023   2022 
General and Administrative Expenses  $79,449   $68,087 
Total stock-based compensation expense  $79,449   $68,087 
Schedule of Stock Option Valuation Assumptions

The fair value of each employee option grant was estimated on the date of grant using the Black-Scholes option pricing model and the following assumptions for the periods indicated:

 

   June 30, 
   2024   2023 
Expected volatility   72%   65% - 75%
Risk-free interest rate   4.1% - 4.4%   0.5% - 3.5%
Expected term   5.7 - 6.1 years    5.9 - 6.0 years 
Expected dividend   0%   0%

The fair value of each employee option grant was estimated on the date of grant using the Black-Scholes option pricing model and the following assumptions for the periods indicated:

 

   December 31, 
   2023   2022 
Expected volatility   65% - 75%   65% - 75%
Risk-free interest rate   0.5% - 3.5%   0.5% - 2.8%
Expected term   5.9 - 6.0 years    5.9 - 6.0 years 
Expected dividend   0%   0%